References in periodicals archive ?
Angionetics' Generx regulatory dossier on file with the FDA represents one of the most extensive and advanced DNA-based clinical data platforms ever compiled, positioning Angionetics as the world's leader in the field of cardiovascular angiogenic gene therapy.
San Diego, CA; 858-794-3420) announced the issuance of United States Patent 6,174,871 entitled "Gene Therapies for Enhancing Cardiac Function," which is directed to angiogenic gene therapy methods for treating heart disease.
The issuance of this patent serves to solidify Collateral Therapeutics' proprietary position in angiogenic gene therapy for the non-surgical treatment of cardiovascular disease," observed Jack W.